PATIENTS WITH NOREPINEPHRINE-REFRACTORY VASOPLEGIC SHOCK

Clinical trials for PATIENTS WITH NOREPINEPHRINE-REFRACTORY VASOPLEGIC SHOCK explained in plain language.

Never miss a new study

Get alerted when new PATIENTS WITH NOREPINEPHRINE-REFRACTORY VASOPLEGIC SHOCK trials appear

Sign up with your email to follow new studies for PATIENTS WITH NOREPINEPHRINE-REFRACTORY VASOPLEGIC SHOCK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for ICU patients in Life-Threatening shock

Disease control Not yet recruiting

This study aims to see if adding a drug called argipressin (vasopressin) to standard treatment helps adults in intensive care who have a severe form of shock that isn't responding to the usual first medication. It will test if this combination improves 30-day survival, reduces th…

Matched conditions: PATIENTS WITH NOREPINEPHRINE-REFRACTORY VASOPLEGIC SHOCK

Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

PATIENTS WITH NOREPINEPHRINE-REFRACTORY VASOPLEGIC SHOCK

Get alerted when new PATIENTS WITH NOREPINEPHRINE-REFRACTORY VASOPLEGIC SHOCK trials appear

New hope for ICU patients in Life-Threatening shock